Deciphering the genetic underpinnings of neuroticism: A Mendelian randomization study of druggable gene targets
Yanggang Hong,
No information about this author
Yi Wang,
No information about this author
Wanyi Shu
No information about this author
et al.
Journal of Affective Disorders,
Journal Year:
2024,
Volume and Issue:
370, P. 147 - 158
Published: Nov. 2, 2024
Language: Английский
APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Abstract
APOE4
is
the
leading
genetic
risk
factor
for
Alzheimer’s
disease,
and
chronic
stress
a
environmental
factor.
Studies
suggest
that
confers
vulnerability
to
behavioral
neuropathological
effects
of
stress,
representing
potential
mechanism
by
which
this
variant
accelerates
onset
progression.
Whether
how
-mediated
manifests
in
neurons
hippocampus,
brain
region
particularly
susceptible
pathology,
remains
unexplored.
Using
combination
vivo
vitro
experiments
humanized
APOE3
knockin
mice
primary
hippocampal
from
these
animals,
we
investigate
whether
sensitivity
glucocorticoids,
main
hormones.
We
find
major
hallmark
stress/glucocorticoid-induced
damage,
tau
pathology
(i.e.,
accumulation,
hyperphosphorylation,
spreading)
exacerbated
versus
mice.
Moreover,
animals
exhibit
underlying
mitochondrial
dysfunction
enhanced
glucocorticoid
receptor
activation
factors
likely
contribute
pathogenesis
both
presence
absence
stress/glucocorticoids.
Supporting
concept,
show
opening
permeability
transition
pore
drives
mice,
pharmacological
inhibition
protective
against
ApoE4-mediated
phosphorylation
spreading,
downstream
synapse
loss.
These
findings
shed
light
on
mechanisms
carriers
identify
as
therapeutic
target
ameliorating
population.
Language: Английский
Impact of corticoid receptors on Alzheimer’s disease: a neuroendocrine perspective
Falguni Goel,
No information about this author
Daksh Kumar,
No information about this author
Anushka Sharma
No information about this author
et al.
Inflammopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 18, 2025
Language: Английский
Dexmedetomidine Reduces Chronic Stress–Related Thrombosis in a Mouse FeCl3 Model
Huazhen Wang,
No information about this author
Meiping Zhang,
No information about this author
Minglong Xin
No information about this author
et al.
The FASEB Journal,
Journal Year:
2025,
Volume and Issue:
39(9)
Published: April 30, 2025
ABSTRACT
Chronic
psychological
stress
(CPS)
is
a
significant
risk
factor
for
thrombotic
cardio‐cerebrovascular
diseases
(TCVDs).
Clinical
data
suggest
that
the
α
2
‐adrenergic
receptor
(AdR‐α
)
agonist
dexmedetomidine
(Dex)
can
influence
coagulation
in
stress‐exposed
intensive
care
unit
patients.
Given
important
role
of
protease‐activated
receptor‐2
(PAR‐2)
vascular
pathobiology,
we
aimed
to
investigate
potential
effects
Dex
on
stress‐related
thrombus
formation,
focusing
PAR‐2
signaling
pathway.
Eight‐week‐old
male
mice
underwent
non‐stress
and
immobilization
with
treatment
weeks
were
then
subjected
carotid
artery
thrombosis
induction
using
ferric
chloride
(FeCl
3
).
On
Day
14
post‐stress,
exhibited
increased
weight
length,
along
harmful
alterations
plasma
levels
von
Willebrand
metalloproteinase
thrombospondin
Type
13
motifs.
Additionally,
arterial
protein
and/or
mRNA
PAR‐2,
p‐Akt,
Bcl‐2,
cleaved
caspase‐3,
cytochrome
c
,
gp91
phox
TNF‐α,
MCP‐1,
ICAM‐1,
VCAM‐1,
TLR‐4
altered,
accompanied
by
endothelial
loss.
reversed
these
changes.
Conversely,
AdR‐α2
blockage
yohimbine
diminished
benefits
Dex.
In
vitro,
reduced
serum‐induced
reactive
oxygen
species
production
apoptosis,
beneficial
levels.
Yohimbine
effects.
Thus,
activation
appeared
mitigate
formation
undergoing
FeCl
‐induced
surgery,
possibly
negatively
regulating
signaling.
These
findings
therapeutic
strategy
CPS‐related
events
patients
TCVDs.
Language: Английский
How can early stress influence later Alzheimer risk? Possible mediators and underlying mechanisms.
Biological Psychiatry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
Language: Английский
Hippocampal Synaptic Plasticity: Integrating Memory and Anxiety Impairments in the Early Stages of Alzheimer’s Disease
Current topics in behavioral neurosciences,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Language: Английский
Ketamine reverses chronic stress-induced behavioral changes via the expression of Ca2+-permeable AMPA receptors in mice
Joshua C. Flowers,
No information about this author
Paige E. Vetter,
No information about this author
McKennon J Wiles
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 7, 2024
Abstract
Background
and
Purpose
Chronic
stress
affects
brain
functions
leading
to
the
development
of
mental
disorders
like
anxiety
depression,
as
well
cognitive
decline
social
dysfunction.
Among
many
biological
changes
in
chronically
stressed
brains,
disruptions
AMPA
Receptor
(AMPAR)-mediated
synaptic
transmission
hippocampus
are
associated
with
responses.
We
have
revealed
that
low-dose
ketamine
rapidly
induces
expression
GluA1-containing,
GluA2-lacking
Ca
2+
-Permeable
AMPARs
(CP-AMPARs),
which
enhances
glutamatergic
strength
hippocampal
neurons.
Additionally,
subanesthetic
decreases
anxiety–
depression-like
behaviors
naïve
animals.
In
addition
reducing
some
research
indicates
may
protective
effects
against
chronic
both
humans
However,
role
CP-AMPARs
actions
ketamine’s
antistress
is
largely
unknown.
Experimental
Approach
use
whole-cell
patch-clamp
recordings
from
CA1
pyramidal
neurons
female
male
slices
multiple
behavioral
assays
including
reciprocal
interaction,
contextual
fear
conditioning,
tail
suspension
test.
Key
Results
demonstrate
treatment
reverses
restraint
(CRS)-induced
dysfunction,
hippocampus-dependent
memory
loss,
behavior
mice.
Furthermore,
we
show
ketamine-induced
on
these
dependent
CP-AMPAR
expression.
Conclusion
Implications
Our
findings
suggest
triggers
hippocampus,
antidepressant
effects.
Language: Английский
Neurotrophic Effects of Foeniculum vulgare Ethanol Extracts on Hippocampal Neurons: Role of Anethole in Neurite Outgrowth and Synaptic Development
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12701 - 12701
Published: Nov. 26, 2024
Foeniculum
vulgare
Mill,
commonly
known
as
fennel,
is
an
aromatic
herb
traditionally
used
for
culinary
and
medicinal
purposes,
with
potential
therapeutic
effects
on
neurological
disorders.
However,
limited
research
has
focused
its
neurotrophic
impact,
particularly
neuronal
maturation
synaptic
development.
This
study
investigates
the
of
F.
ethanol
extracts
(FVSE)
rat
primary
hippocampal
neurons.
Results
show
that
FVSE
prominent
component,
anethole,
significantly
promote
neurite
outgrowth
in
a
dose-dependent
manner.
Optimal
axonal
dendritic
growth
occurred
at
concentrations
40
µg/mL
20
µM
respectively,
without
causing
cytotoxicity,
underscoring
safety
health.
Additionally,
enhances
formation
synapses,
essential
communication.
Network
pharmacology
analysis
revealed
components
influence
critical
pathways,
including
PI3K-AKT
Alzheimer’s
disease
pathways.
Specifically,
modulates
key
proteins,
tropomyosin
receptor
kinase
(Trk),
glycogen
synthase
3
(GSK3βser9),
phosphatidylinositol
3-kinase
(PI3K),
extracellular
signal-regulated
protein
(Erk1/2).
Anethole
was
found
to
play
role
regulating
these
which
confirmed
by
immunocytochemistry
experiments
demonstrating
effect
promoting
In
conclusion,
this
highlights
properties
FVSE,
anethole
emerging
bioactive
compound.
These
findings
provide
valuable
insights
into
fennel
treating
disorders,
offering
basis
future
interventions
survival.
Language: Английский